Copertina

PARP inhibitor‐based treatment in metastatic, castration‐resistant prostate cancer (mCRPC): A systematic review and meta‐analysis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Michela Roberto, Mattia Alberto Di Civita, Daniele Marinelli, Andrea Torchia, Nertila Cara, Giulia Maltese, Iolanda Speranza, Daniele Santini
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	BJUI Compass
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Transperineal prostate biopsy with freehand technique under local anaesthetic: A systematic review and meta‐analysis
di: Benjamin M. Mac Curtain, et al.
Pubblicazione: (2025)

Development of a novel risk model to predict CRPC progression following IMRT: Implications for tailoring treatment intensity
di: Takashi Ogata, et al.
Pubblicazione: (2025)

A systematic review and network meta‐analysis comparing Rezūm with transurethral needle ablation and microwave thermotherapy for the management of enlarged prostate
di: Ansh Bhatia, et al.
Pubblicazione: (2024)

Increased risk of bleeding during and after HoLEP in patients with prostate cancer: A multicentre comparative cohort study
di: Angelo Porreca, et al.
Pubblicazione: (2025)

Comparing outcomes of Aquablation versus holmium laser enucleation of prostate in the treatment of benign prostatic hyperplasia: A network meta‐analysis
di: Ansh Bhatia, et al.
Pubblicazione: (2024)

Perioperative alpha blockers in voiding dysfunction secondary to prostate biopsy: A meta‐analysis
di: Sean Lim, et al.
Pubblicazione: (2024)

Analysis of urinary volatile organic compounds for prostate cancer diagnosis: A systematic review
di: Jonathon Dawson, et al.
Pubblicazione: (2024)

Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
di: Maxwell Louis Sandberg, et al.
Pubblicazione: (2026)

Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
di: Eric Margolis, et al.
Pubblicazione: (2025)

Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
di: Esther H. J. Hamoen, et al.
Pubblicazione: (2025)

Ureteral stent symptoms: A systematic review and meta‐analysis comparing the use of mirabegron and tamsulosin
di: Daniel Madarshahian, et al.
Pubblicazione: (2025)

The carbon footprint of transperineal prostate biopsy
di: Daniel A. Carson, et al.
Pubblicazione: (2025)

Emerging tools for the early detection of prostate cancer
di: Muhammad Haider, et al.
Pubblicazione: (2025)

Quality of English‐ and Spanish‐language online content about prostate cancer genetics: Insights into potential contributors to prostate cancer disparities
di: Sophia M. Abusamra, et al.
Pubblicazione: (2025)

Variation in harms and benefits of prostate‐specific antigen screening for prostate cancer by socio‐clinical risk factors: A rapid review
di: Abel Tesfai, et al.
Pubblicazione: (2024)

Bibliometric analysis of focal therapy in prostate cancer research
di: Mohammed Shahait, et al.
Pubblicazione: (2024)

Primary urethral cancer: Treatment patterns, responses and survival in localized, advanced and metastatic patients
di: Ilfad Blazevic, et al.
Pubblicazione: (2025)

Long‐term outcomes after cytoreductive partial nephrectomy for metastatic renal cell carcinoma
di: Andrea Lopez Sanmiguel, et al.
Pubblicazione: (2026)

‘It Just Makes Sense to Me’: A qualitative study exploring patient decision‐making and experiences with prostate MRI during active surveillance for prostate cancer
di: Ryan Sutherland, et al.
Pubblicazione: (2024)

Micro‐ultrasound tissue echogenicity predicts prostate cancer grade
di: Ailene E. Corona, et al.
Pubblicazione: (2026)

The impact of vaporization on adenoma weight in benign prostatic hyperplasia surgery
di: André B. Silva, et al.
Pubblicazione: (2026)

Targeting genomic receptors in voided urine for confirmation of benign prostatic hyperplasia
di: Mathew Thakur, et al.
Pubblicazione: (2024)

Utility of dynamic contrast enhancement for clinically significant prostate cancer detection
di: Eric V. Li, et al.
Pubblicazione: (2024)

National survey of urologists' views on prostate cancer screening in the United Kingdom
di: Nikhil Mayor, et al.
Pubblicazione: (2026)

Focal therapy in prostate cancer: Development, application and outcomes in the United Kingdom
di: Nadia Rokan, et al.
Pubblicazione: (2025)

Multidisciplinary meetings for lower urinary tract symptoms and benign prostate hyperplasia
di: Emilien Seizilles de Mazancourt, et al.
Pubblicazione: (2025)

Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer
di: Ruth Pidsley, et al.
Pubblicazione: (2024)

WATER versus WATER II 5‐year update: Comparing Aquablation therapy for benign prostatic hyperplasia in 30–80‐cm3 and 80–150‐cm3 prostates
di: Mohamad Baker Berjaoui, et al.
Pubblicazione: (2024)

The significant costs of prostate cancer management—An analysis from a Caribbean hospital
di: Geneva Pantoja, et al.
Pubblicazione: (2025)

Impact of recreational football in men with prostate cancer undergoing androgen deprivation therapy
di: Sofia Mesquita, et al.
Pubblicazione: (2025)

Evaluating the utility of the HAS‐BLED bleeding‐estimator tool for transurethral resection of prostate
di: Lu Yu Kuo, et al.
Pubblicazione: (2025)

Risk factors of negative prostate biopsies: A CHAID decision tree analysis
di: Pierre Allainguillaume, et al.
Pubblicazione: (2026)

Prevention of lymphoceles using peritoneal flaps during robotic‐assisted radical prostatectomy with pelvic lymph node dissection: A systematic review and meta‐analysis
di: Huseyin Yildiz, et al.
Pubblicazione: (2026)

Does total lesion prostate‐specific membrane antigen (PSMA) activity on 68Ga‐PSMA PET/CT correlate with PSA and prostatectomy histopathological/clinical outcomes in patients with localised primary prostate cancer?
di: Jeremy Cheng, et al.
Pubblicazione: (2025)

Real‐world clinical outcomes of oligometastatic prostate cancer using SBRT: An Australian experience
di: Samantha Shekar, et al.
Pubblicazione: (2025)

A machine learning algorithm for automatic tumour board recommendations in prostate cancer patients
di: Marcus Sondermann, et al.
Pubblicazione: (2025)

Reliability of mpMRI in diagnosing cancer prostate following intravesical BCG for bladder cancer
di: Arjun Pon Avudaiappan, et al.
Pubblicazione: (2024)

Sociodemographic landscape of suspected prostate cancer referrals and diagnoses across North East London
di: Muhammad Haider, et al.
Pubblicazione: (2025)

AI‐enhanced micro‐ultrasound improves detection of clinically significant prostate cancer at biopsy
di: Muhammad Imran, et al.
Pubblicazione: (2026)

Potential gains from radical treatment of men with prostate cancer according to life expectancy
di: Sandra Irenaeus, et al.
Pubblicazione: (2025)